Abstract
In this study, Subphthalocyanine (SubPc) and SubPc integrated TiO2 nanoparticles (SubPc- TiO2) were examined as theranostic agents. In vitro photodynamic therapy (PDT) efficiency of SubPc/SubPc-TiO2 and nuclear imaging potential of 131I labeled SubPc/TiO2-SubPc were determined on hepatocellular carcinoma (HepG2), colorectal adenocarcinoma (HT29) and human healthy lung (WI38) cell lines. As a result, 131I-SubPc and 131I-SubPc-TiO2 have been identified as a nuclear imaging agent for liver cancer. Additionally, 131I-SubPc-TiO2 has been found to be promising for imaging colon tumors. According to the in vitro photodynamic therapy studies, SubPc and SubPc-TiO2 were determined suitable PDT agents for liver and colon tumors. These results suggest that SubPc-TiO2 might be a theranostic agent with both PDT and nuclear imaging potential.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Photochemistry and Photobiology A: Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
